Ambrisentan is a propanoic acid, non-sulfonamide, selective endothelin type A (ETA) receptor antagonist which is used in pulmonary arterial hypertension (PAH) which a fatal and progressive disease with poor prognosis. This slide set enumerates the efficacy, safety, indication, dosing and place in therapy of ambrisentan in PAH.